MedPath

Diagnosis of Pulmonary Embolism by Doppler Signals

Not Applicable
Terminated
Conditions
Pulmonary Embolism
Interventions
Radiation: Diagnostic ultrasound radiation
Registration Number
NCT02652689
Lead Sponsor
Echosense Ltd.
Brief Summary

The LDS may contain information of significant diagnostic and physiological value regarding the pulmonary parenchyma and vasculature, as well as the cardio- vascular system in general. In pilot clinical studies of patients with acute decompensated heart failure (ADHF) as well as patients with Pulmonary Hypertension, LDS signals patterns unique to these conditions were identified. We believe that these newly discovered ultrasound signals might provide a non-invasive radiation-free means to diagnose and monitor patients with Pulmonary Embolism.

The purpose of this study is to assess the utility of noninvasive assessment of lung Doppler signals performed via transthoracic parametric Doppler. The objective of the study is to evaluate the lung Doppler signals (LDS) in patients diagnosed with acute PE, in order to determine the potential assessment value of this non-invasive method in this potentially life threatening condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Confirmed diagnosis of acute PE on CTA
Exclusion Criteria
  • Pregnant women
  • Inability to consent
  • Patients with severe chest wall deformity
  • Previously diagnosed PE
  • Pneumonia
  • Pulmonary edema
  • Pneumothorax
  • Severe COPD (gold class III, IV)
  • Hemodynamically unstable patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diagnostic ultrasoundDiagnostic ultrasound radiationRecording Doppler ultrasound signals noninvasively from the right chest wall
Primary Outcome Measures
NameTimeMethod
Identify lack of Lung Doppler signals in specific lung sections that were diagnosed obstructed by CT30min

The obstructed sections will be compared with healthy lung sections

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath